Gilles Houvenaeghel

17PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 13, 2026
Small Triple-Negative and HER2-Positive Early Breast Cancer: Upfront Surgery or Neoadjuvant Chemotherapy?

|Jul 08, 2025
Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer.

Stéphane Fattori, Laurent Gorvel, Marie-Sarah Rouviére

|Apr 21, 2025
Neoadjuvant treatment and premastectomy radiotherapy: oncological and surgical outcomes.

Marie Bannier, Monique Cohen, Agnès Tallet

|Oct 16, 2024
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.

Gilles Houvenaeghel, Jean-Marc Classe, Marie-Pierre Chauvet

|Aug 10, 2024
Omission of Completion Axillary Lymph Node Dissection for Patients with Breast Cancer Treated by Upfront Mastectomy and Sentinel Node Isolated Tumor Cells or Micrometastases.

Gilles Houvenaeghel, Mellie Heinemann, Jean-Marc Classe

|Mar 28, 2024
Does Breast Surgery Type Alter Incidental Axillary Irradiation? A Dosimetric Analysis of the "Sentinel Envahi et Randomisation du Curage" SERC Trial.

Camille Nicolas, Claire Petit, Agnès Tallet

Pageof 3

Frequent Collaborators

4 joint publications

Anthony Gonçalves

4 joint publications

Alexandre de Nonneville

3 joint publications

Jean-Marc Classe

3 joint publications

Eric Lambaudie